Hip fractures in the elderly caused by falls, not osteoporosis

 

Helsinki, Finland, (May 27, 2015) – Anti-osteoporotic medication is not an effective means for preventing hip fractures among the elderly, concludes a study recently published in the BMJ. Proximal femoral fractures (i.e., hip fractures) occur in the world at a rate of 1.5 million per year, or 7,000 per year in Finland. As most such fractures occur among older people, their number is expected to grow as the population ages. Hip fractures often lead to permanently reduced mobility, quality of life and general health, as well as result in significant social costs.


Since the early 1990s, anti-osteoporotic medication has been used to reduce bone fractures among the elderly, of which hip fractures are the most severe. Many thought that slowing down bone loss could prevent fractures. The criteria for evaluating the risk for fracture were originally drafted based on bone density measurements. The criteria used by current bone fracture risk calculators indicate that most women over the age of 65 are in need of medication. In the USA, for example, 75% of Caucasian women over the age of 65 are considered to be in the risk group. This has created a massive market for osteoporosis medication and bone density measuring equipment.

 

The international research group led by Professor Teppo Järvinen, University of Helsinki, Finland, studied the efficacy of anti-osteoporotic medication in preventing hip fractures by reviewing all publications on the topic (i.e., the scientific basis of the current treatment strategy).

 

The results from this meta-analysis were shocking.

 

"The benefit from the drug treatment is marginal at best. It also seems – and this is an interesting detail – that the better the response to the treatment in the study, the more flaws the study had," Järvinen explains.

 

One notable problem was the age distribution of study participants. Most hip fractures occur in patients over the age of 80, but the studies focus on a significantly younger group. "Only three studies have been conducted on subjects 80 years of age or older, and none of them found that the medication prevented hip fractures," Järvinen says.

Werbung

 

The researchers who performed the meta-analysis concluded that the idea of preventing hip fractures with anti-osteoporotic medication is fundamentally flawed, since the brittleness of the bones does not significantly affect the occurrence of bone fractures among older people.

 

"Hip fractures are the result of falls or similar small accidents. Even if the older person has brittle bones, they are unlikely to fracture without an accident. Asking questions about balance disorders provides a more accurate understanding of the patient’s risk for bone fracture than taking bone density measurements," states Järvinen.

 

 

Health risks and wasted resources

 

Overdiagnosing the fracture risk and the resulting overtreatment are bad for both the patients and the health care system, the researchers point out. Being labelled "at risk" can be psychologically detrimental, and fear of fractures can cause the patient to stop engaging in active exercise, which in turn worsens health. Osteoporosis medication also comes with its own harmful side effects.

 

"When the treatment is drug-focused, other factors that contribute more significantly to the risk for fractures are easily overlooked, such as smoking, exercise, and solutions which may prevent falls," Järvinen points out.

 

 

The study appeared in the "Too Much Medicine" series of articles published by the BMJ. The series highlights the health and financial problems caused by overdiagnosis and unnecessary treatment.

 

 


University of Helsinki, 27.05.2015 (tB).

MEDICAL NEWS

Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds
Monoclonal antibody therapy for COVID-19 safe, effective for transplant patients
Having trouble falling asleep predicts cognitive impairment in later life
SARS-CoV-2 detectable — though likely not transmissible — on hospital…

SCHMERZ PAINCARE

Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern
Wenn Schmerzen nach einer OP chronisch werden

DIABETES

Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…
Minimalinvasive Geräte warnen ungenügend vor Unterzuckerung
Typ-1-Diabetes und Hashimoto-Thyreoiditis treten häufig gemeinsam auf

ERNÄHRUNG

DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren
Gesundheitliche Auswirkungen des Salzkonsums bleiben unklar: Weder der Nutzen noch…

ONKOLOGIE

Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung
Risikobasiertes Brustkrebs-Screening kosteneffektiv
Krebs – eine unterschätzte finanzielle Herausforderung

MULTIPLE SKLEROSE

Neuer Biomarker bei Multipler Sklerose ermöglicht frühe Risikoeinschätzung und gezielte…
Multiple Sklerose beginnt oft lange vor der Diagnose
Goldstandard für Versorgung bei Multipler Sklerose
Patienteninformationen zu Interferon-beta-Präparaten
Zulassung des S1P Modulators Ponesimod zur Behandlung von erwachsenen Patienten…

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung